Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
about
What is the Role for Intra-Arterial Therapy in Acute Stroke Intervention?Imaging of prehospital stroke therapeuticsTargeting integrin and integrin signaling in treating thrombosis.A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic strokeAdvances in medical revascularisation treatments in acute ischemic stroke.Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke TrialPhase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.Advances and challenges in treatment and prevention of ischemic stroke.Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.Clinical trials in acute ischemic stroke.Alteplase in acute ischemic stroke: putting the guidelines into practice.Treatment of acute stroke: an update.Effect of waivers of consent on recruitment in acute stroke trials: A systematic reviewChanging Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy.Peptide hormones and lipopeptides: from self-assembly to therapeutic applications.An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?Adjunctive medical therapies for acute stroke thrombolysis: is there a CLEAR-ER choice?Emergency and critical care management of acute ischaemic stroke.Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke.Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update.Glycoprotein IIb/IIIa Inhibitor Bridging and Subsequent Endovascular Therapy in Vertebrobasilar Occlusion in 120 Patients.
P2860
Q26796472-59C09CCF-C2B7-4F44-B55C-113B30911DBFQ26797275-BB2D27C4-53D5-4582-B5AA-41415EC56F5AQ33417854-7200034F-F8FA-4B11-941C-BD9ACF2CF935Q33671141-7A2BFB22-18F5-4980-9207-42BC7350CB48Q34459133-7491FAD4-E679-422F-98D9-106B38538BBFQ35019813-1B1ADE7F-7AB9-4053-99A1-D4D241A2CADBQ35998267-59ABC774-A1B2-4F15-B83E-7F9C1BCF0B2DQ37670794-D3B4DAD6-F5E0-4507-9612-203EAE0BF6C6Q38127644-A71309DD-BD97-4695-A7EB-7A1137ED0FF1Q38225341-42AA5520-015C-4187-B761-0F7ABAB5AF98Q38243696-5B21AAA2-B302-49A4-B517-CC381D38265EQ38261206-F98008DC-F8DA-4621-B30B-0830FDF64703Q38541197-9C7DD77A-43F5-43AD-A8A4-1DFD50E0F901Q38786616-FC55DB9C-A893-42A4-B774-1A44FDEB5E25Q38790291-4EA095C8-2B57-479E-BF1D-D37C350D7E9FQ39106145-3068C8A0-EB6B-46E0-A241-C5152A726E4BQ40523644-502C4178-0866-461F-B66C-F0A894C67354Q41678659-ED42027E-2B3D-45CD-861B-C3349C1D3ED2Q42857714-71167F14-A9C3-419F-8444-70D526459FCAQ48458092-921C1A70-4723-4C81-AC1E-E938DF130B84Q48558308-E60D0CEF-4592-437F-987E-B44EB127FBD6Q50053948-2C1263C4-4F61-4AF0-90EA-0A09BA809938Q51060040-707EA4A3-8191-4432-B003-40B0ED81DFD2
P2860
Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@en
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@nl
type
label
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@en
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@nl
prefLabel
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@en
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@nl
P2093
P2860
P1433
P1476
Combined approach to lysis uti ...... enhanced regimen stroke trial.
@en
P2093
Alexander Schneider
Arthur M Pancioli
Brett C Meyer
CLEAR-ER Investigators
Claudette E Brooks
Dawn Kleindorfer
Heidi Sucharew
James S McKinney
Jane Khoury
Joseph P Broderick
P2860
P304
P356
10.1161/STROKEAHA.113.001059
P407
P577
2013-07-25T00:00:00Z